Level C· Early human research exploring benefitsProspective StudyPubMed

The anterolateral thigh as a universal donor site for soft tissue reconstruction in maxillofacial surgery.

Wolff KD., Kesting M., Thurmüller P., Böckmann R., Hölzle F.

Prospective Study with a reported sample of 187 on Scar, published in J Craniomaxillofac Surg (2006) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Craniomaxillofac Surg (2006)
Country
Scotland
Reported sample size
187
Source database
PubMed
PMID
16860992
DOI
10.1016/j.jcms.2006.04.002

Abstract (original English)

The experience with 191 flaps from the anterolateral thigh is described with special regard to variations of vascular anatomy and possible flap designs. Since 1992, 191 flaps from the anterolateral thigh donor site were used in 187 patients. The size of the defects varied from 3 x 5 cm to 21 x 10 cm, being located in nearly all areas of the head and neck region including the skull base. The functional and aesthetic outcome was routinely evaluated during follow-up of the patients. All complications and secondary procedures were documented during the whole follow-up period ranging from 4 weeks to 11.2 years. Six different patterns of variations were observed concerning the flap pedicle, but none of these resulted in failure of flap raising except for two patients, in whom no perforators could be found. Poor functional results were observed in 17 patients, and debulking procedures or scar revisions were carried out in 58 of the 187 patients. Nine flap types reaching from voluminous and large myocutaneous flaps to ultra-thin cutaneous perforator flaps were used, enabling closure of virtually any type of soft tissue defect. Twelve flaps were lost, resulting in a success rate of 93.7%. Due to the combined advantages of minimal donor site morbidity, the option of simultaneous flaps and the satisfying results, the anterolateral thigh can be considered a universal donor site which is id

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAdolescentAdultAgedAged, 80 and overChildFemaleHumansMaleMiddle Aged

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research